(Q45873672)

17 December 2017

title

Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

Coagulation factor VIII

0 references

hemophilia A

0 references

author name string

Rocino A

1

1 reference

17 December 2017

Papa ML

2

1 reference

17 December 2017

Salerno E

3

1 reference

17 December 2017

Capasso F

4

1 reference

17 December 2017

Miraglia E

5

1 reference

17 December 2017

de Biasi R

6

1 reference

17 December 2017

publication date

1 January 2001

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

33-38

1 reference

17 December 2017

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Tolerance induction using the Malmö treatment model 1982-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Analysis of the North American Immune Tolerance Registry (NAITR) 1993-1997: current practice implications. ISTH Factor VIII/IX Subcommittee Members

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

The German National Immune Tolerance Registry, 1997 update. Study Group of German Haemophilia Centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Comparison of the international immune tolerance registry and the North American immune tolerance registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

Immune tolerance: a synopsis of the international experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2001.00461.X

10.1046/J.1365-2516.2001.00461.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017